What do I need to consider regarding Forschungszulage and the corporate income tax return (Körperschaftsteuererklärung)?

Date: March 14, 2026•Author: Erich Lehmann

Summary

Forschungszulage (public funding) is a government tax benefit for R&D projects: after assessment by the tax office (Finanzamt), it is generally offset against the assessed corporate income tax (Körperschaftsteuer) and can—if the tax is insufficient—be paid out as a surplus (also possible in loss years). For Forschungszulage in the corporate income tax return (Forschungszulage in der Körperschaftsteuererklärung), the process is decisive: first the BSFZ certificate, then the application for assessment with the tax office, followed by correct accounting treatment (P&L) and entry in Appendix WA/12.

From 2026, the allowance will become even more attractive for many companies—especially due to a higher assessment base (up to €12 million) as well as a flat-rate overhead-/operating cost component (20%).

Why is Forschungszulage so attractive—especially for corporate income tax?

Forschungszulage (public funding) is one of the most straightforward ways to financially support research and development (R&D)—regardless of industry, company size, or legal form, as long as you are tax liable in Germany and have an eligible R&D project.

What makes it so strong:

  • Offset against corporate income tax (directly reduces the payment) or payout if there is no/too low tax burden
  • Retroactively applicable (up to 4 years)
  • Tax-free funding (as a tax refund / offset)
  • From 2026 even more attractive for many companies (e.g., higher assessment base, flat-rate overhead)

You can also find more fundamentals and practical know-how at dieforschungszulage.de.


Forschungszulage & corporate income tax return (Körperschaftsteuererklärung): The process (clearly explained in 3 steps)

If you search for "forschungszulage körperschaftsteuererklärung", in practice it almost always comes down to this process:

1) BSFZ application: have the project certified

First, you apply for the certification of your R&D project's eligibility in the portal of the BSFZ (Bescheinigungsstelle Forschungszulage).

Official point of contact: BSFZ portal via the federal government's central page:

2) Application for assessment with the tax office (Finanzamt)

The BSFZ certificate alone does not yet lead to a payout/offset. You then submit the application for assessment with the tax office. Only then is the amount assessed and offset against the next corporate income tax assessment—or paid out.

3) Accounting + corporate income tax return (entry)

Important: Forschungszulage (public funding) affects the corporate income tax return indirectly, because it is usually already reflected in the annual financial statements.

Typical core point:

  • Recognition in the P&L under "other operating income" (depending on timing and accounting logic)

Where do I enter Forschungszulage in the corporate income tax return (Körperschaftsteuererklärung)?

In practice, Forschungszulage (public funding) is recorded in the corporate income tax return primarily in Appendix WA/12 (Forschungszulage) (e.g., around lines 41–44—depending on the current form version).

If the assessment notice (Festsetzungsbescheid) is not yet available, a solution via "Further information" (Appendix WA) may be useful depending on the case, so that the offset does not slip into the wrong assessment period.


Forschungszulage corporate income tax (Körperschaftsteuer): What applies if I don't pay taxes?

A major advantage (and often underestimated): You can receive Forschungszulage (public funding) even if your company does not pay corporate income tax (e.g., in a loss year). If the allowance exceeds the tax debt—or if there is none—the difference is paid out.

Especially for start-ups, tech companies, and high-growth firms, this can be a real liquidity lever.


What changes from 2026—and why is this relevant?

With the reforms from 2026, Forschungszulage (public funding) becomes even more interesting for many companies, among other things due to:

  • higher assessment base (up to €12 million per financial year)
  • flat-rate overhead (20% surcharge)
  • continued offset against tax or payout

If you need guidance on which setup fits you (SME/not SME, cost types, application years), it's best to start with the overview at dieforschungszulage.de.

More details in the overview of changes 2024 and 2026.


Guide: Correctly reflecting Forschungszulage in DATEV (practical checklist)

Step-by-step (conceptual, DATEV-ready)

  1. File documentation cleanly

  2. Recognize the income correctly in the annual financial statements

    • Forschungszulage (public funding) is typically posted as other operating income
    • Timing: depends on whether entitlement requirements/accounting recognition criteria are met as of the reporting date (when in doubt, seek tax advice)
  3. Check the tax reconciliation

    • Ensure that recognition in the financial statements is processed consistently in the tax computation (P&L → tax balance sheet/reconciliation statement)
  4. Corporate tax return: complete Appendix WA/12

    • Forschungszulage is reported in the return in Appendix WA/12
    • If the notice is not yet available: check whether information/applications are required so that the offset timing fits
  5. Plausibility checks & supporting documentation function

    • In DATEV: take plausibility checks seriously (resolve error messages/review notes)
    • Document vouchers/notes so that the file is audit-proof

If you want specific instructions for your DATEV setup (which program, which client type, which financial statement/tax workflow), write to us via dieforschungszulage.de—then it can be aligned cleanly to the process. This guide follows the exact steps from Datev itself here: https://help-center.apps.datev.de/documents/1020617


Conclusion: Forschungszulage + corporate income tax return = liquidity without "classic grant logic"

Forschungszulage (public funding) is an excellent option because it is tax-free, retroactively usable, and not dependent on profits. Anyone doing R&D should plan it strategically in the annual financial statements and the corporate income tax return (Körperschaftsteuererklärung)—especially with a view to its increased attractiveness from 2026.

Do you still have questions about this topic?

We are happy to discuss your specific case in a free initial consultation. We'll find out in just a few minutes how much funding your company can receive.

Call Now
Erich - Your Contact Person